Report Categories Report Categories

Report Categories

industry Category

All

Total: 4 records, 1 pages

Global Recombinant Coagulation Factor Concentrate Supply, Demand and Key Producers, 2024-2030

date 19 Nov 2024

date Pharma & Healthcare

new_biaoQian Recombinant Coagulation Factor Concentrate

The global Recombinant Coagulation Factor Concentrate market size is expected to reach $ million by 2030, rising at a market growth of %CAGR during the forecast period (2024-2030).

USD4480.00

Add To Cart

Add To Cart

Global Recombinant Coagulation Factor Concentrate Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 19 Nov 2024

date Pharma & Healthcare

new_biaoQian Recombinant Coagulation Factor Concentrate

According to our (Global Info Research) latest study, the global Recombinant Coagulation Factor Concentrate market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.

USD3480.00

Add To Cart

Add To Cart

Global Recombinant Coagulation Factor Concentrate Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 27 Feb 2023

date Pharma & Healthcare

new_biaoQian Recombinant Coagulation Factor Concentrate

Coagulation factor is the main drug for the treatment of hemophilia, and it has experienced the evolution and development from the first generation blood-derived coagulation factor products to the second generation recombinant products and the third generation long-acting recombinant products. Recombinant coagulation factors avoid the possibility of human infection and get rid of the dependence on plasma; long-acting products improve patient compliance and treatment convenience by prolonging the half-life of drugs, and long-acting recombinant coagulation factors are the trend of future research and development.

USD3480.00

Add To Cart

Add To Cart

Global Recombinant Coagulation Factor Concentrate Supply, Demand and Key Producers, 2023-2029

date 22 Jan 2023

date Pharma & Healthcare

new_biaoQian Recombinant Coagulation Factor Concentrate

The global Recombinant Coagulation Factor Concentrate market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

USD4480.00

Add To Cart

Add To Cart

industry 19 Nov 2024

industry Pharma & Healthcare

new_biaoQian Recombinant Coagulation Factor Concentrate

The global Recombinant Coagulation Factor Concentrate market size is expected to reach $ million by 2030, rising at a market growth of %CAGR during the forecast period (2024-2030).

USD4480.00

addToCart

Add To Cart

industry 19 Nov 2024

industry Pharma & Healthcare

new_biaoQian Recombinant Coagulation Factor Concentrate

According to our (Global Info Research) latest study, the global Recombinant Coagulation Factor Concentrate market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.

USD3480.00

addToCart

Add To Cart

industry 27 Feb 2023

industry Pharma & Healthcare

new_biaoQian Recombinant Coagulation Factor Concentrate

Coagulation factor is the main drug for the treatment of hemophilia, and it has experienced the evolution and development from the first generation blood-derived coagulation factor products to the second generation recombinant products and the third generation long-acting recombinant products. Recombinant coagulation factors avoid the possibility of human infection and get rid of the dependence on plasma; long-acting products improve patient compliance and treatment convenience by prolonging the half-life of drugs, and long-acting recombinant coagulation factors are the trend of future research and development.

USD3480.00

addToCart

Add To Cart

industry 22 Jan 2023

industry Pharma & Healthcare

new_biaoQian Recombinant Coagulation Factor Concentrate

The global Recombinant Coagulation Factor Concentrate market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

USD4480.00

addToCart

Add To Cart